IL11 and metabolic dysfunction-associated steatohepatitis: In conclusion, we propose a model for lipotoxicity-driven NAFLD-to-NASH transitions whereby lipid-laden hepatocytes secrete IL11 leading to autocrine hepatocyte metabolic dysfunction and cell death along with paracrine activation of neighbouring HSCs and other cells (Fig. 7).